Market Place
Sourcing Support
Absci Partners With Memorial Sloan Kettering On Cancer Antibodies
13 Aug 2024 //
FIERCE BIOTECH
Absci Announces Collaboration with AZ to Advance AI-Driven Oncology Candidate
04 Dec 2023 //
PRESS RELEASE
Almirall and Absci announce AI drug discovery partnership
14 Nov 2023 //
BUSINESSWIRE
Absci Expands in Europe, Adds Senior Leadership in Switzerland
10 Mar 2023 //
CONTRACT PHARMA
Absci Appoints Andreas Busch as Chief Innovation Officer
04 Oct 2022 //
GLOBENEWSWIRE
Absci Reports Second Quarter 2022 Financial Results and Business Update
11 Aug 2022 //
PRESS RELEASE
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference
01 Aug 2022 //
PRESS RELEASE
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Conference
01 Aug 2022 //
PRESS RELEASE
Merck leans into AI with $610 in biobucks for Absci
08 Jan 2022 //
FIERCEBIOTECH
Absci Opens Door to New Biotechnology Campus
25 Oct 2021 //
CONTRACTPHARMA
EQRx`s affordable drug drive leads to Absci discovery pact
07 Oct 2021 //
FIERCEBIOTECH
CerraCap Ventures portfolio company Totient acquired by Absci
07 Jul 2021 //
BIOSPACE
AbSci Acquires Cell Therapy Company Totient
17 Jun 2021 //
CONTRACTPHARMA
AbSci Announces Acquisition of Target Discovery Company Totient
15 Jun 2021 //
PRNEWSWIRE
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci
15 Jun 2021 //
BIOSPACE
AbSci Announces Completion of $125 Million Crossover Financing to AI-Powered
23 Mar 2021 //
PRNEWSWIRE
AbSci Announces Strategic Investment by Merck Global Health Innovation Fund
22 Feb 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.